Your browser doesn't support javascript.
loading
What are the obligations of pharmaceutical companies in a global health emergency?
Emanuel, Ezekiel J; Buchanan, Allen; Chan, Shuk Ying; Fabre, Cécile; Halliday, Daniel; Heath, Joseph; Herzog, Lisa; Leland, R J; McCoy, Matthew S; Norheim, Ole F; Saenz, Carla; Schaefer, G Owen; Tan, Kok-Chor; Wellman, Christopher Heath; Wolff, Jonathan; Persad, Govind.
Afiliação
  • Emanuel EJ; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: zemanuel@upenn.edu.
  • Buchanan A; Department of Philosophy, University of Arizona, Tucson, AZ, USA.
  • Chan SY; Department of Politics, Princeton University, Princeton, NJ, USA.
  • Fabre C; All Souls College, University of Oxford, Oxford, UK.
  • Halliday D; Department of Philosophy, University of Melbourne, Melbourne, VIC, Australia.
  • Heath J; Munk School of Global Affairs and Public Policy, University of Toronto, Toronto, ON, Canada.
  • Herzog L; Faculty of Philosophy, University of Groningen, Groningen, Netherlands.
  • Leland RJ; Department of Philosophy, University of Manitoba, Winnipeg, MB, Canada.
  • McCoy MS; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Norheim OF; Bergen Centre for Ethics and Priority Setting, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Saenz C; Department of Health Systems and Services, Pan American Health Organization, Washington, DC, USA.
  • Schaefer GO; Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Tan KC; Department of Philosophy, University of Pennsylvania, Philadelphia, PA, USA.
  • Wellman CH; Department of Philosophy, Washington University, St Louis, MO, USA.
  • Wolff J; Blavatnik School of Government, University of Oxford, Oxford, UK.
  • Persad G; Sturm College of Law, University of Denver, Denver, CO, USA.
Lancet ; 398(10304): 1015-1020, 2021 09 11.
Article em En | MEDLINE | ID: mdl-34364412

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Responsabilidade Social / Saúde Global / Custos e Análise de Custo / Indústria Farmacêutica Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Responsabilidade Social / Saúde Global / Custos e Análise de Custo / Indústria Farmacêutica Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article